Visterra Inc.
Jeffrey Kuniholm, PhD, currently serves as a Senior Scientist at Visterra Inc. since April 2022, following a role as a Scientist with the same company from April 2015 to July 2017. Prior to this, Jeffrey was a Graduate Researcher at Boston University School of Medicine from September 2017 to April 2022, where research focused on HIV transcription in the Henderson Laboratory and vaccine immune response mechanisms in the Wetzler Laboratory. Earlier experience includes a Research Associate position at MassBiologics from May 2013 to April 2015, specializing in monoclonal antibody screening and purification, and a Research Assistant role at Genzyme in 2012, concentrating on rare muscular diseases. Jeffrey earned a Bachelor's degree in Biochemistry from Northeastern University from 2008 to 2013.
Visterra Inc.
1 followers
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.